RENAL CELL CARCINOMA STAGE IV

This adverse event was reported 103 times

These drugs are most commonly taken by patients reporting RENAL CELL CARCINOMA STAGE IV:

# Drug Count
0 SUNITINIB MALATE 26
1 PAZOPANIB HYDROCHLORIDE 18
2 SORAFENIB 16
3 METOPROLOL TARTRATE 13
4 METOPROLOL 11
5 OMEPRAZOLE MAGNESIUM 10
6 ESOMEPRAZOLE MAGNESIUM 9
7 MESALAMINE 9
8 AXITINIB 7
9 ESOMEPRAZOLE SODIUM 7
See all common drugs associated with RENAL CELL CARCINOMA STAGE IV

RENAL CELL CARCINOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NALBUPHINE HYDROCHLORIDE 1 0.0080
1 POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS 1 0.0055
2 PAZOPANIB HYDROCHLORIDE 18 0.0009
3 SORAFENIB 16 0.0009
4 VINBLASTINE SULFATE 1 0.0008
5 SUNITINIB MALATE 26 0.0007
6 MINERAL OIL AND PETROLATUM 1 0.0006
7 DIMENHYDRINATE 2 0.0006
8 AXITINIB 7 0.0006
9 POLYVINYL ALCOHOL, POVIDONE 1 0.0006
See all drugs enriched for association with RENAL CELL CARCINOMA STAGE IV

RENAL CELL CARCINOMA STAGE IV is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cannabinoid [EPC] 1 0.0001
1 Stimulant Laxative [EPC] 1 0.0001
2 Aminosalicylate [EPC] 9 0.0001
3 Kinase Inhibitor [EPC] 29 0.0001
4 Prostaglandin E1 Analog [EPC] 1 0.0001
5 Non-Standardized Food Allergenic Extract [EPC] 1 0.0001
6 Potassium-sparing Diuretic [EPC] 1 0.0001
7 Phenothiazine [EPC] 1 0.0000
8 Non-Standardized Chemical Allergen [EPC] 1 0.0000
9 5-alpha Reductase Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with RENAL CELL CARCINOMA STAGE IV